Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

Free Abstracts

  Schizophrenia

  Free Subscription


22.01.2018

1 Biol Psychiatry
1 J Clin Psychiatry
1 Mol Psychiatry
1 Neuropsychopharmacology
2 PLoS One
6 Psychiatry Res
3 Psychol Med
5 Schizophr Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biol Psychiatry

  1. FRANKLE WG, Paris J, Himes M, Mason NS, et al
    Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.
    Biol Psychiatry. 2017 Dec 7. pii: S0006-3223(17)32255.
    PubMed     Text format     Abstract available


    J Clin Psychiatry

  2. PERKINS DO
    Improving Long-Term Outcomes in Patients With Schizophrenia: What Is the Evidence for Long-Acting Injectable Antipsychotics?
    J Clin Psychiatry. 2017;78:e1431.
    PubMed     Text format     Abstract available


    Mol Psychiatry

  3. LEGGE SE, Hamshere ML, Ripke S, Pardinas AF, et al
    Genome-wide common and rare variant analysis provides novel insights into clozapine-associated neutropenia.
    Mol Psychiatry. 2017;22:1502-1508.
    PubMed     Text format     Abstract available


    Neuropsychopharmacology

  4. BERNSTEIN HG, Dobrowolny H, Keilhoff G, Bogerts B, et al
    Reduced Density of DISC1 Expressing Astrocytes in the Dentate Gyrus but not in the Subventricular Zone in Schizophrenia.
    Neuropsychopharmacology. 2018;43:457-458.
    PubMed     Text format    


    PLoS One

  5. YERABHAM ASK, Muller-Schiffmann A, Ziehm T, Stadler A, et al
    Biophysical insights from a single chain camelid antibody directed against the Disrupted-in-Schizophrenia 1 protein.
    PLoS One. 2018;13:e0191162.
    PubMed     Text format     Abstract available

  6. PALACIOS-CENA D, Martin-Tejedor EA, Elias-Elispuru A, Garate-Samaniego A, et al
    The impact of a short-term cohousing initiative among schizophrenia patients, high school students, and their social context: A qualitative case study.
    PLoS One. 2018;13:e0190895.
    PubMed     Text format     Abstract available


    Psychiatry Res

  7. DENG H, Mohite S, Suchting R, Nielsen DA, et al
    Impact of synthetic cannabinoid use on hospital stay in patients with bipolar disorder versus schizophrenia, or other psychotic disorders.
    Psychiatry Res. 2018;261:248-252.
    PubMed     Text format     Abstract available

  8. BEHDANI F, Roudbaraki SN, Saberi-Karimian M, Tayefi M, et al
    Assessment of the efficacy of omega-3 fatty acids on metabolic and inflammatory parameters in patients with schizophrenia taking clozapine and sodium valproate.
    Psychiatry Res. 2017;261:243-247.
    PubMed     Text format     Abstract available

  9. SURI G, Lavaysse LM, Young G, Moodie C, et al
    An investigation into the drivers of avolition in schizophrenia.
    Psychiatry Res. 2018;261:225-231.
    PubMed     Text format     Abstract available

  10. KULKARNI K, Arasappa R, Prasad M K, Zutshi A, et al
    Risperidone versus olanzapine in the acute treatment of Persistent Delusional Disorder: A retrospective analysis.
    Psychiatry Res. 2017;253:270-273.
    PubMed     Text format     Abstract available

  11. KOIKE S, Yamaguchi S, Ojio Y, Ando S, et al
    Social distance toward people with schizophrenia is associated with favorable understanding and negative stereotype.
    Psychiatry Res. 2018;261:264-268.
    PubMed     Text format     Abstract available

  12. SOYATA AZ, Akisik S, Inhanli D, Noyan H, et al
    Relationship of obsessive-compulsive symptoms to clinical variables and cognitive functions in individuals at ultra high risk for psychosis.
    Psychiatry Res. 2018;261:332-337.
    PubMed     Text format     Abstract available


    Psychol Med

  13. PADULA MC, Schaer M, Armando M, Sandini C, et al
    Cortical morphology development in patients with 22q11.2 deletion syndrome at ultra-high risk of psychosis.
    Psychol Med. 2018 Jan 17:1-9. doi: 10.1017/S0033291717003920.
    PubMed     Text format     Abstract available

  14. BALLESTEROS A, Sanchez-Torres AM, Lopez-Ilundain JM, Cabrera B, et al
    Is cognitive impairment associated with antipsychotic dose and anticholinergic equivalent loads in first-episode psychosis?
    Psychol Med. 2018 Jan 14:1-10. doi: 10.1017/S0033291717003774.
    PubMed     Text format     Abstract available

  15. ZWICKER A, Denovan-Wright EM, Uher R
    Gene-environment interplay in the etiology of psychosis.
    Psychol Med. 2018 Jan 15:1-12. doi: 10.1017/S003329171700383.
    PubMed     Text format     Abstract available


    Schizophr Res

  16. CHESTKOV IV, Jestkova EM, Ershova ES, Golimbet VE, et al
    Abundance of ribosomal RNA gene copies in the genomes of schizophrenia patients.
    Schizophr Res. 2018 Jan 11. pii: S0920-9964(18)30001.
    PubMed     Text format     Abstract available

  17. LIMONGI R, Bohaterewicz B, Nowicka M, Plewka A, et al
    Knowing when to stop: Aberrant precision and evidence accumulation in schizophrenia.
    Schizophr Res. 2018 Jan 10. pii: S0920-9964(17)30770.
    PubMed     Text format     Abstract available

  18. ADAMCZYK P, Wyczesany M, Domagalik A, Cepuch K, et al
    Diminished activation of the right Inferior Parietal Lobule as a neural substrate of impaired cartoon-jokes comprehension in schizophrenia outpatients.
    Schizophr Res. 2018 Jan 9. pii: S0920-9964(18)30004.
    PubMed     Text format    

  19. ROTSTEIN A, Roe D, Gelkopf M, Shadmi E, et al
    Quality of life disparities between persons with schizophrenia and their professional caregivers: Network analysis in a National Cohort.
    Schizophr Res. 2018 Jan 8. pii: S0920-9964(17)30769.
    PubMed     Text format     Abstract available

  20. TOROUS J, Keshavan M
    A new window into psychosis: The rise digital phenotyping, smartphone assessment, and mobile monitoring.
    Schizophr Res. 2018 Jan 12. pii: S0920-9964(18)30005.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Schizophrenia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: